Forum Discussion
Disappointing news.
I just read on face book that CDK inhibitor Ribociclib has been rejected for listing on the PBS. This is very very disappointing news when we have metastatic breast cancer and are always hoping that ...
I doubt very much the average person could afford to pay so much money. I know I couldn't. I also wonder what happens if say my breast cancer comes back in other parts of my body will this drug work as I've already had it.